Jul 06, 2026
Dharwad (Karnataka) [India], July 6: Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement with Orion Corporation for intravenous (IV) nivolumab biosimilar referencing one of the world's most widely used cancer immunotherapies to widen patient access across Europe.
Read More...
Jul 06, 2026
Mumbai (Maharashtra) [India], July 6: Investment in Indian startups fell by 8.3% in the most recent full...
Jul 06, 2026
Mumbai (Maharashtra) [India], July 6: Yuthika Professional, a professional hair color, hair care, and styling brand, has...
Jul 05, 2026
Jakarta [Indonesia], July 5: Indonesia's carbon trading ecosystem is fully prepared for implementation to support sustainable economic...
